top of page

OUR SCIENCE

Lama Bioscience is a gene therapy biotech company that is dedicated to developing cutting-edge treatments for genetic diseases using innovative approaches for large gene engineering and delivery. Our team of scientists and researchers are focused on discovering and developing therapies that can target specific genes and a wide range of genetic mutations, with the ultimate goal of providing effective, safe and durable treatments for patients suffering from genetic diseases. By leveraging our expertise in RNA and gene therapy, we are committed to advancing the field of genetic medicine and bringing hope to patients and families affected by genetic disorders.

Human Machine

01

AI-POWERED VECTOR AND DESIGN PLATFORM

Our Vector and RNA Design Platform is an AI-powered tool that uses machine learning algorithms to optimize the design of gene therapy vectors. The platform takes into account a variety of factors, such as the type of disease, target tissue, and desired level of gene expression, to generate vector designs that are tailored to each specific application. By leveraging the power of AI, our Vector Design Platform can rapidly generate and evaluate thousands of vector and RNA designs, allowing us to identify the most promising candidates for further testing and development. This platform is a key part of our gene therapy development pipeline, and we believe it has the potential to accelerate the development of new and effective gene therapies for a wide range of diseases.

02

HIGH-THROUGHPUT SCREENING PLATFORM

Our High-throughput Screening Platform is a state-of-the-art tool that enables the rapid screening of large numbers of potential drug candidates. The platform uses advanced automation and robotics technology to quickly and efficiently test the biological activity of thousands of compounds against a specific drug target. By identifying candiates that show the desired biological activity, we can rapidly generate a list of promising drug candidates for further testing and development. Our High-throughput Screening Platform is a key part of our drug discovery pipeline, and we believe it has the potential to accelerate the development of new and effective therapies for a wide range of diseases.

Science Lab
Petri Dish

03

VECTOR AND RNA ENGINEERING PLATFORM

Our Vector and RNA Engineering Platform is a cutting-edge tool that enables the rapid design and construction of gene therapy vectors. The platform uses advanced molecular biology techniques to modify and optimize the properties of viral vectors, such as their tropism, immunogenicity, and gene expression kinetics. By leveraging the power of this platform, we can rapidly generate high-quality gene therapy vectors that are optimized for each specific application. Our Vector and RNA Engineering Platform is a key part of our gene therapy development pipeline, and we believe it has the potential to accelerate the development of new and effective gene therapies for a wide range of diseases.

04

DURG VERIFICATION PLATFORM

Our Drug Verification Platform is an advanced tool that enables the comprehensive characterization and validation of gene therapy vectors. The platform uses a variety of techniques, such as next-generation sequencing, qPCR, and functional assays, to evaluate the quality and performance of gene therapy vectors. By leveraging the power of this platform, we can ensure that our vectors meet the highest standards of safety, efficacy, and consistency. Our drug Verification Platform is a key part of our gene therapy development pipeline, and we believe it has the potential to accelerate the development of new and effective gene therapies for a wide range of diseases.

A Closer Look
bottom of page